Literature DB >> 6840409

Hepatic secretion of bilirubin and biliary lipids in patients with alcoholic cirrhosis of the liver.

R Raedsch, A Stiehl, U Gundert-Remy, S Walker, A Sieg, P Czygan, B Kommerell.   

Abstract

In patients with cirrhosis of the liver elevated bilirubin concentrations in the plasma could be the result of decreased bilirubin excretion or an overproduction of bilirubin with insufficient excretion of the increased amounts of bilirubin. Under steady state conditions with constant serum bilirubin concentrations bilirubin synthesis equals biliary and urinary bilirubin excretion. In the present study in 10 healthy volunteers and 11 patients with alcoholic cirrhosis of the liver and serum bilirubin concentrations of 7.0 +/- 1.9 mg/dl the biliary excretion of bilirubin was studied by the intestinal perfusion method and compared with the excretion of bile lipids. Biliary excretion of bilirubin in the cirrhotics was 38.7 +/- 8.8 mumol/h, the 10 healthy controls excreted 17.9 +/- 0.9 mumol/h bilirubin. Only minor amounts of bilirubin were excreted in urine. In 4 of the 11 cirrhotics 51Cr-red blood cell half-lives were studied revealing ongoing hemolysis. Bilirubin production calculated from red cell life span was identical to biliary excretion of bilirubin with an error less than 5%. The data indicate that in patients with alcoholic cirrhosis of the liver serum concentrations of bilirubin may be elevated due to overproduction of bilirubin and a concomitant decrease of the biliary transport capacity of bilirubin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840409     DOI: 10.1159/000198872

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

Review 1.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

Review 2.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

3.  Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.

Authors:  Juan P Arab; Rosa M Martin-Mateos; Vijay H Shah
Journal:  Hepatol Int       Date:  2017-05-26       Impact factor: 6.047

4.  Human gallbladder mucosal function: effects on intraluminal fluid and lipid composition in health and disease.

Authors:  S Ginanni Corradini; G Yamashita; H Nuutinen; A Chernosky; C Williams; L Hays; M L Shiffman; R M Walsh; J Svanvik; P Della Guardia; L Capocaccia; R T Holzbach
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 5.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

Review 6.  The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease.

Authors:  Liang Zhao; Shaoxuan Wang; Nanhai Zhang; Jingxuan Zhou; Arshad Mehmood; Rifat Nowshin Raka; Feng Zhou; Lei Zhao
Journal:  Antioxidants (Basel)       Date:  2022-06-20

7.  Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation.

Authors:  W H Schwesinger; W E Kurtin; B A Levine; C P Page
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

Review 8.  Gallstones in Patients with Chronic Liver Diseases.

Authors:  Xu Li; Xiaolin Guo; Huifan Ji; Ge Yu; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-01-31       Impact factor: 3.411

9.  The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease.

Authors:  Phillipp Hartmann; Wei-Chung Chen; Bernd Schnabl
Journal:  Front Physiol       Date:  2012-10-11       Impact factor: 4.566

Review 10.  Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2014-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.